Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...

SAB-142 was generally well-tolerated among healthy volunteers; data from Phase 1 trial confirms SAB-142 does not cause serum sickness or ...

West Virginia University microbiologists have identified an antibody that can kill one of the most drug-resistant bacteria.

Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.

Traditionally carrying a dire prognosis, the treatment paradigm for multiple myeloma is changing, with CAR T therapies, ...

But as it stands now, anyone can call themselves a coach without formal training. 3 The differences in approach between coaching and therapy are often misunderstood. For example, one misconception is ...

SOTIO’s new ADC candidate aimed at the treatment of colorectal cancer and other gastrointestinal (GI) cancers. Biocytogen’s innovative RenMice ® platform offers an extensive library of fully human ...

Anger management therapy can include a host of different therapies such as cognitive behavioral therapy or psychodynamic therapy. Your therapist or psychologist will tailor any chosen therapy to ...

1 Despite several treatment options, including approved thrombopoietin receptor agonists and commonly used antibody-reducing approaches—such as B-cell depletion with the anti-CD20 monoclonal antibody ...